Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | ACACB | O00763 | 1/20 | 0.32 |
| ▸ | HCRTR2 | O43614 | 3/20 | 0.31 |
| ▸ | ALOX5AP | P20292 | 6/20 | 0.31 |
| ▸ | FEN1 | P39748 | 6/20 | 0.31 |
| ▸ | TYR | P14679 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11939184 | 1.00 | KDM4E (0.36) | KDM4EL3MBTL1HTR1AACACBHCRTR2 | |
| SCHEMBL12223922 | 0.96 | KDM4E (0.34) | KDM4EL3MBTL1HTR1AACACB | |
| SCHEMBL12223915 | 0.96 | KDM4E (0.39) | KDM4EL3MBTL1HTR1AACACBHCRTR2 | |
| SCHEMBL11939055 | 0.91 | NAAA (0.35) | KDM4EL3MBTL1HTR1AACACBALOX5AP | |
| SCHEMBL11939245 | 0.91 | NAAA (0.35) | KDM4EL3MBTL1HTR1AACACBALOX5AP | |
| SCHEMBL12224613 | 0.89 | HTR1A (0.32) | KDM4EL3MBTL1HTR1A | |
| SCHEMBL10303265 | 0.89 | KDM4E (0.34) | KDM4EL3MBTL1HTR1AACACBHCRTR2 | |
| SCHEMBL11939348 | 0.87 | — | — | |
| SCHEMBL12223982 | 0.87 | HTR1A (0.32) | KDM4EL3MBTL1HTR1A | |
| SCHEMBL12223913 | 0.87 | NAAA (0.36) | KDM4EL3MBTL1HTR1AACACBHCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120168677-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120168677-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | CXCR1, OCIAD1, LEO1 | KDM4E 4164/4885L3MBTL1 141/4885HTR1A 425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.